Scientist / Scientist 2 / Senior Scientist
Surrozen
Summary
Surrozen is seeking a Scientist to conduct in vivo efficacy studies in support of drug development programs in the ophthalmology space. The successful candidate will also contribute to establishing and optimizing advanced in vivo model systems, leveraging state-of-the-art technologies and techniques to help elucidate drug mechanism of action.
Job description
Key Responsibilities
- Develop and optimize disease and injury models for characterization of lead molecules
- Conduct independent in vivo studies and contribute to collaborative activities
- Perform extensive hands-on in vivo work including animal handling, compound administration, surgical procedures, and tissue collection
- Perform tissue sample analysis such as ELISA, qPCR, immunohistochemistry, and imaging
- Systematically analyze complex experimental data, critically evaluate and interpret data, draw conclusions, and present findings to project teams to guide drug development decisions
- Work closely with cross-functional teams, including protein biochemists, pharmacologists, and data scientists, to drive discovery programs
- Engage with and oversee work conducted by contract research organizations (CROs) for specialized tasks, and coordinate projects with research partners
- Develop and maintain communication with a network of scientific advisors and consultants
- Stay current with scientific literature and contribute to setting the strategic direction for discovery efforts in the ophthalmology therapeutics field
- Maintain accurate, well-organized experimental records and present research progress at team and departmental meetings
- Publish data and research discoveries as conference abstracts, patents and peer-reviewed papers as guided by Surrozen publication strategy
Requirements
- PhD in cell and molecular biology, neuroscience, retinal or vascular biology, or a related biological discipline
- Strong record of peer-reviewed publications
- Minimum of 5 years of hands-on research experience in Wnt biology or a related field
- Demonstrated experience in rodent handling, restraint, and dosing
- Technical expertise in preclinical ophthalmology in vivo techniques including FA, OCT, ERG, and ocular injection
- Strong proficiency in standard laboratory techniques including DNA and RNA extraction, PCR, ELISA, Western blot, immunostaining, and microscopy
- Experience in integrating AI agents into scientific discovery and drug development workflow
- Proficiency with Microsoft Office, SharePoint, GraphPad Prism, electronic laboratory notebook software, and cloud-based tools
- Excellent organizational and communication skills
- Attention to detail, data oriented, problem solving, self-motivated
- Experience in coaching junior scientists and research staff
- Strong interpersonal skills and a team player
Benefits
- Health Insurance
- Dental Insurance
- Vision Insurance
- 401(k) Retirement Plan
- IRA
- Life Insurance
- Paid Time Off
- Family Leave
- Short & Long Term Disability
- Training & Development
- Free Food & Snacks
- Wellness Resources
- Stock Option Plan
Company overview
Surrozen is a biotechnology company pioneering the development of novel therapeutics that selectively activate the Wnt signaling pathway for tissue repair and regeneration. The company's proprietary platform technology, called SWAP (Surrozen Wnt-Activating Platform), enables the creation of targeted biologics that can precisely modulate Wnt signaling in specific tissues and cell types. This approach addresses one of the major challenges in regenerative medicine - achieving controlled activation of Wnt signaling without the safety concerns associated with broad pathway activation. Surrozen's pipeline focuses on developing treatments for serious diseases in multiple therapeutic areas, including gastrointestinal, ocular, and neurological disorders. The company's innovative technology represents a significant advancement in the field of regenerative medicine, offering the potential to restore tissue function and treat degenerative conditions through precise biological engineering. Surrozen's research aims to unlock the therapeutic potential of Wnt signaling, a fundamental pathway in development and tissue homeostasis, to create transformative medicines for patients with unmet medical needs.